Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02106949
Other study ID # SIAM
Secondary ID RB 13-068 [CHRU
Status Active, not recruiting
Phase Phase 3
First received April 4, 2014
Last updated March 15, 2018
Start date August 2014
Est. completion date August 2019

Study information

Verified date March 2018
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study wants to prove that SMS monitoring reduced the number of suicide attempts in six months according to the beginning of its implementation in the group of the patients benefiting SMS compared with the group of patients benefiting from the usual care.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 530
Est. completion date August 2019
Est. primary completion date May 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Written informed consent

- Surviving a suicide attempt

- Leaving directly the emergency department or hospitalized less than 7 days

- Being able to be joined by telephone mobile

Exclusion Criteria:

- under guardianship

- Patient who are not able to provide a consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
SMS contact with patient after discharge in intervention group


Locations

Country Name City State
France CHU Angers Angers
France CHRU de Brest Brest
France CHU Caen Caen
France CHRU Lille Lille
France CHU de Lyon Lyon
France CHU Nantes Nantes
France CH Quimperlé Quimperlé
France CHU Rennes Rennes
France CHU de Saint-Etienne, Hôpital Nord Saint Etienne
France CH St Malo St Malo
France CHU St Nazaire St Nazaire
France CHU Tours Tours
France CH Vannes Vannes

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Brest Technopôle Brest-Iroise: LANESTEL SARL, 38 rue Jim Sevellec, 29200 Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of suicide reattempts in every group 6 months
Secondary Number of suicide reattempts in every group 13 months
Secondary Total number of suicidal second recurrences in every group 6 months
Secondary Total number of suicidal second recurrences in every group 13 months
Secondary Number of deaths by suicide 6 months and 13 months
Secondary Score in the scale C-SSRS inclusion, 6 months and 13 months
Secondary Presence of a disorder in the MINI: characterization of the comorbidity 6 months and 13 months